AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YAMAGUCHI, N.
Right arrow Articles by GLASS, G. B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YAMAGUCHI, N.
Right arrow Articles by GLASS, G. B. J.
Agricola
Right arrow Articles by YAMAGUCHI, N.
Right arrow Articles by GLASS, G. B. J.

American Journal of Clinical Nutrition, Vol 23, 156-164, Copyright © 1970 by The American Society for Clinical Nutrition, Inc.

Study of the Intestinal Absorption of 51Cr-Labeled Intrinsic Factor

NOBUO YAMAGUCHI 1, WILLIAM S. ROSENTHAL 1, and GEORGE B. JERZY GLASS 1

1 From the Gastroenterology Research Laboratory and Section of Gastroenterology, Department of Medicine, New York Medical College, New York, New York

To evaluate the possibility that intrinsic factor is absorbed from the gastrointestinal tract, intrinsic factor from human and hog sources was partially purified by ion-exchange column chromatography and gel filtration and labeled by incubation with 51CrCl3. The labeled product retained the characteristics of intrinsic factor, as measured by electrophoretic behavior, ability to bind B12, stability on acid incubation when bound to B12, and ability to enhance B12 uptake by guinea pig intestine mucosal homogenate. The 51Cr hog intrinsic factor concentrate retained its activity when tested in patients with pernicious anemia.

The labeled intrinsic factor preparations were administered, bound either to radioactive or nonradioactive B12, to four normal volunteers and seven individuals with deficient or absent intrinsic factor secretion. Study of the absorption of both labels by radioactivity measurements of urine, feces, and plasma, as well as hepatic surface scintillation counting, and, in the case of 3 normal subjects, whole-body counting, demonstrated no significant absorption of the 51Cr label. There was evidence, however, of absorption of radioactive B12, which further substantiated the intrinsic factor activity of the labeled preparation.

Our data do not support the contention that the intrinsic factor molecule enters the circulation from the intestine in the process of B12 absorption in an intact state. This does not exclude the possibility that unlabeled fragments of intrinsic factor may enter the circulation from the intestine or that intrinsic factor may enter into the circulation from the gastric mucosa as a result of an endocrine-exocrine partition under pathological conditions.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by The American Society for Nutrition